Literature DB >> 7914964

Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy?

S O'Rahilly1, A Hattersley, A Vaag, H Gray.   

Abstract

Non-insulin-dependent diabetes (NIDDM) is a heterogeneous state involving various degrees of beta-cell dysfunction and insulin resistance, although the relative importance of these two factors is controversial. Several single gene disorders of carbohydrate metabolism have their main pathophysiological defect largely restricted to the beta-cell or to insulin-sensitive tissues. We have noted that with insulin resistance the fasting plasma glucose is often normal and severe hyperglycaemia occurs after a glucose load. By contrast, in glucokinase-deficient diabetes, which is characterised by reduced insulin secretion, the reverse is the case. Supportive evidence showing that beta-cell dysfunction and insulin resistance may have different effects on fasting and post-prandial glucose concentrations comes from studies of identical twins of NIDDM patients, hemi-pancreatectomised normal subjects, and insulin-resistant Asian subjects. NIDDM is usually preceded by a period of less severe hyperglycemia, referred to as impaired glucose tolerance (IGT). Studies of the IGT phase usually conclude that insulin resistance is the major abnormality and is thus the primary defect in NIDDM. However, the definition of IGT is based on the 2 h plasma glucose after an oral glucose-tolerance test without consideration of the fasting glucose concentrations (provided these concentrations are non-diabetic). Our observations suggest that this definition of IGT may result in the over-representation of insulin-resistant individuals and the under-representation of subjects with beta-cell dysfunction in any cross sectional study of IGT. The belief that the prediabetic state of IGT is dominated by insulin resistance may be a self-fulfilling prophesy because of the excessive emphasis put on the post-prandial rather than the fasting state.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914964     DOI: 10.1016/s0140-6736(94)91969-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function.

Authors:  N Stefan; A Fritsche; F Machicao; O Tschritter; H U Häring; M Stumvoll; M Stumvogel
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

Review 2.  The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?

Authors:  K Faerch; C Brøns; A C Alibegovic; A Vaag
Journal:  J Physiol       Date:  2010-01-25       Impact factor: 5.182

3.  Examination of the fasting and 2-h plasma glucose in the light of impairment in beta-cell function: what does the epidemiological data tell us?

Authors:  Suhail A R Doi; Glenn M Ward
Journal:  Endocrine       Date:  2014-06-01       Impact factor: 3.633

4.  Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

Authors:  K Faerch; K Borch-Johnsen; J J Holst; A Vaag
Journal:  Diabetologia       Date:  2009-07-10       Impact factor: 10.122

Review 5.  The Role of Nutraceutical Containing Polyphenols in Diabetes Prevention.

Authors:  Iva Fernandes; Joana Oliveira; Aryane Pinho; Eugenia Carvalho
Journal:  Metabolites       Date:  2022-02-17

6.  Urtica dioica modulates hippocampal insulin signaling and recognition memory deficit in streptozotocin induced diabetic mice.

Authors:  Sita Sharan Patel; Sahil Gupta; Malairaman Udayabanu
Journal:  Metab Brain Dis       Date:  2016-01-14       Impact factor: 3.584

7.  Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle.

Authors:  K Sebeková; V Spustová; R Dzúrik
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 8.  Monogenic diabetes and pregnancy.

Authors:  Rinki Murphy
Journal:  Obstet Med       Date:  2015-06-29

9.  Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains.

Authors:  Shuiping Liu; Jing Li; Mei-Hua Chen; Zhenqi Liu; Weibin Shi
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

10.  Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.

Authors:  Henrik H Hansen; Helene M Ægidius; Denise Oró; Simon S Evers; Sara Heebøll; Peter Lykke Eriksen; Karen Louise Thomsen; Anja Bengtsson; Sanne S Veidal; Michel Feigh; Malte P Suppli; Filip K Knop; Henning Grønbæk; Diego Miranda; James L Trevaskis; Niels Vrang; Jacob Jelsing; Kristoffer T G Rigbolt
Journal:  BMC Gastroenterol       Date:  2020-07-06       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.